IR-MED Honors Juneteenth with Commitment to Healthcare Equality: PressureSafe Device Sees Beneath the Skin to Address Inequality in Pressure Injuries
June 12, 2023 09:15 ET
|
IR-Med, Inc.
Early detection of pressure injuries can be challenging for minority populations due to the current method of visual inspectionPatients with dark skin tones suffered more than twice as much as those...
IR-Med Appoints Dr. Lynn Eschenbacher to its Advisory Board as Company Advances Toward Launch of its PressureSafe Wound Care Device
June 07, 2023 09:28 ET
|
IR-Med, Inc.
Innovative executive driving positive outcomes and profitability, Dr. Eschenbacher is focused on addressing healthcare access and equityThrough early, non-invasive detection of pressure injuries,...
IR-Med’s PressureSafe Noninvasive Wound Care Device to be Demonstrated at Northwell Health’s 10th Annual Shining the Light on Wound Care Symposium
May 19, 2023 09:15 ET
|
IR-Med, Inc.
A 94.7% accuracy in identifying Stage 1 pressure injuries was achieved in a proof-of-concept device upon which PressureSafe is basedCompany to exhibit and demo its “sense the invisible” handheld...
IR-Med to present at National Pressure Injury Advisory Panel 2023
March 14, 2023 09:00 ET
|
IR-Med, Inc.
The company’s PressureSafe device is being designed to reduce healthcare disparity in pressure injury detection and treatment Rosh Pina, Israel, March 14, 2023 (GLOBE NEWSWIRE) -- “IR-MED” or the...
IR-MED SIGNS AGREEMENT TO EXPAND ITS PRESSURESAFE DEVICE USABILITY STUDY
February 14, 2023 09:15 ET
|
IR-Med, Inc.
The study will expand to Rabin Medical Center (RMC), in parallel to Beit-Rivka, turning the study to a double center usability study. Rosh Pinna, Israel, Feb. 14, 2023 (GLOBE NEWSWIRE) --...
IR-Med Announces Dr. David Dalton as Advisory Board member
November 16, 2022 09:32 ET
|
IR-Med, Inc.
Dr. Dalton brings decades of experience as a hall of fame CEO, entrepreneur, pharmaceutical executive and founder of over 40 companies Rosh Pinna, Israel, Nov. 16, 2022 (GLOBE NEWSWIRE) --...
IR-Med Signs Agreement for the Commercial Design of the PressureSafe Device
August 30, 2022 09:15 ET
|
IR-Med, Inc.
Rosh Pinna, Israel, Aug. 30, 2022 (GLOBE NEWSWIRE) -- (“IR-MED or the “Company”) (OTCQB:IRME), an innovative medical device company that is developing non-invasive, real-time detection devices...
IR-Med files Provisional Patent Application Covering Additional Features of its PressureSafe Device for Early Detection of Pressure Injuries
August 12, 2022 08:34 ET
|
IR-Med, Inc.
Rosh Pinna, Israel, Aug. 12, 2022 (GLOBE NEWSWIRE) -- (“IR-MED or the “Company”) (OTCQB:IRME), an innovative medical device company, developing non-invasive, real-time detection devices that utilize...
IR-Med To Initiate Useability Study of its PressureSafe Device
June 23, 2022 09:15 ET
|
IR-Med, Inc.
Rosh Pinna, Israel, June 23, 2022 (GLOBE NEWSWIRE) -- (“IR-MED or the “Company”) (OTCQB:IRME), an innovative development stage medical device company that utilizes Infra-Red light spectroscopy (IR)...
IRME Letter to Shareholders
January 11, 2022 16:38 ET
|
IR-Med, Inc.
New York, N.Y., Jan. 11, 2022 (GLOBE NEWSWIRE) -- IR-Med, Inc. (OTCPINK: IRME). Our non-invasive monitoring technology enters the public eye – why I’m so excited for 2022. Dear new, old, and...